Ethical Concerns and Future Directions in Maternal Screening for Down Syndrome

By Elkins T.E.   Brown D.  

Women's Health Issues, Vol. 5, Iss. 1, 1995-03 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

Second trimester maternal serum biochemical screening for Down's syndrome: experience of a single obstetric unit

By Kadir R. A.   Pepera T.   Economides D. L.  

Journal of Obstetrics & Gynaecology, Vol. 19, Iss. 4, 1999-07 ,pp. : 373-376

Informa Healthcare

Access to resources Recommend Favorite

Impaired renal function in the mother may result in a high false positive rate in Down Syndrome screening

By Byrd L.   Baker P.  

Journal of Obstetrics & Gynaecology, Vol. 26, Iss. 4, 2006-05 ,pp. : 376-377

Informa Healthcare

Access to resources Recommend Favorite

In utero transfer: some obstetric considerations

By Alderdice F.  

Prenatal and Neonatal Medicine, Vol. 6, Iss. 5, 2001-10 ,pp. : 323-325

Taylor & Francis Ltd

Access to resources Recommend Favorite

Case Report: Denovo inherited 18p deletion in a mother-fetus pair with extremely variable expression, confirmed by fluorescence in situ hybridization (FISH) analysis.

By Tonk V.   Krishna J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 73, Iss. 2, 1997-06 ,pp. : 193-196

Elsevier

Access to resources Recommend Favorite